402 related articles for article (PubMed ID: 28449687)
1. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
2. TUFM is a potential new prognostic indicator for colorectal carcinoma.
Shi H; Hayes M; Kirana C; Miller R; Keating J; Macartney-Coxson D; Stubbs R
Pathology; 2012 Oct; 44(6):506-12. PubMed ID: 22772342
[TBL] [Abstract][Full Text] [Related]
3. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma.
Kawasaki Y; Monden T; Morimoto H; Murotani M; Miyoshi Y; Kobayashi T; Shimano T; Mori T
Am J Clin Pathol; 1992 Feb; 97(2):244-9. PubMed ID: 1546693
[TBL] [Abstract][Full Text] [Related]
6. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.
Xu X; Huang A; Cui X; Han K; Hou X; Wang Q; Cui L; Yang Y
Theranostics; 2019; 9(14):4208-4220. PubMed ID: 31281542
[TBL] [Abstract][Full Text] [Related]
8. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.
Hao XP; Günther T; Roessner A; Price AB; Talbot IC
Mol Pathol; 1998 Feb; 51(1):26-9. PubMed ID: 9624416
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
13. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S
J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253
[TBL] [Abstract][Full Text] [Related]
14. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
15. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
16. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
17. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.
Yao T; Utsunomiya T; Nagai E; Oya M; Tsuneyoshi M
Pathol Int; 1996 Dec; 46(12):962-7. PubMed ID: 9110348
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Simsek BC; Pehlivan S; Karaoglu A
Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
